Ignite Creation Date:
2025-12-24 @ 4:52 PM
Ignite Modification Date:
2026-01-06 @ 8:06 PM
Study NCT ID:
NCT00531050
Status:
COMPLETED
Last Update Posted:
2012-05-23
First Post:
2007-09-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-08
Start Date Type:
None
Primary Completion Date:
2008-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-06
Completion Date Type:
ACTUAL
First Submit Date:
2007-09-17
First Submit QC Date:
None
Study First Post Date:
2007-09-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-07-29
Results First Submit QC Date:
None
Results First Post Date:
2012-05-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-04-23
Last Update Post Date:
2012-05-23
Last Update Post Date Type:
ESTIMATED